Thalamic atrophy a biomarker of multiple sclerosis
Researchers from Australia and the Czech Republic conducted a study imaging the brains of 216 patients who had experienced clinically isolated syndrome, a short-term neurological episode which often precedes MS diagnosis.
The patients had several MRIs over two years.
At the end of the study, 92 of them (nearly 43%) converted to MS.
The researchers found thalamic atrophy was independently associated with development of MS, making it “an ideal biomarker”.